Le Lézard
Classified in: Health, Business
Subjects: PDT, OTC, CXP

RESTANCE to Open Condom Manufacturing Plant in Kenya to Enter $9.6 Billion Market


SPARKS, Nevada, October 17, 2017 /PRNewswire/ --

RESTANCE, Inc. (USOTC: ANCE) today announced plans to open a condom manufacturing plant in Kenya to produce condoms for all Africa.  Research and Markets reports the global condom market is expected to reach US $9.6 Billion by 2021 at CAGR of 8.2%.  The United Nations reports that condom usage in Africa is growing and is expected to continue growing until 2030.  RESTANCE has already acquired the tools to equip a manufacturing plant and is in negotiations to manufacture and distribute for a major global brand name.  CEO Randell Torno met recently with the Kenyan Ambassador to the United Sates, H.E. Robinson Githae to discuss investment in Kenya.

RESTANCE is pursuing several business lines in the growing economies of East Africa. The Company is developing opportunities in the region including initiatives in technology and systems integration services, utility support services, affordable housing and health products manufacturing. RESTANCE recently acquired East African Development Partners as part of its strategy in East Africa.

Learn more about the RESTANCE operations in Africa on the Company's website:http://www.restanceinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Randell Torno
[email protected] 
+1-800-834-5792

SOURCE RESTANCE, Inc.


These press releases may also interest you

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...



News published on and distributed by: